Arca
Skip to content
Tools
Tools

-kin

An interleukin-type protein: a version of one of the immune system's signalling molecules.

  • Drugs ending in -kin: 32
  • Approved somewhere: 4
  • With a US drug page: 3

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-kin
Class
Interleukins and similar immune signalling proteins
Most common targets
Interleukin-2 receptor (2), EEF2 (2), IL10RA, IL10RB (1), IL10RB, IL22RA1 (1), IL11RA (1), IL2RB, IL2RG (1), IL1R1 (1), IL18R1, IL18RAP (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -kin or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
PegilodecakinPhase 3IL10RA, IL10RBIL-10 receptor agonist
IlodecakinPhase 1——
Eflepedocokin alfaPhase 2IL10RB, IL22RA1IL22 Receptor agonist
Efmarodocokin alfaPhase 1——
Edodekin alfaPhase 2——
Efarindodekin alfaPhase 2——
OprelvekinApprovedIL11RAInterleukin 11 receptor alpha agonist
DenenicokinPhase 2——
Efineptakin alfaPhase 2——
Atexakin alfaPhase 1——
NavepdekinraPhase 2——
PitrakinraPhase 2——
AldesleukinApprovedInterleukin-2 receptorInterleukin-2 receptor agonist
Denileukin diftitoxApprovedEEF2, Interleukin-2 receptorElongation factor 2 inhibitor
BempegaldesleukinPhase 3——
Efavaleukin alfaPhase 2——
Efercoleukin alfaPhase 2——
Interleukin 15, recombinant non-glycosylatedPhase 2——
Onvapegleukin alfaPhase 2——
PegenzileukinPhase 2IL2RB, IL2RGIL-2R beta/gamma agonist
RezpegaldesleukinPhase 2——
DarleukinPhase 1——
Melredableukin alfaPhase 1——
Nemvaleukin alfaPhase 1——
AnakinraApprovedIL1R1Interleukin-1 receptor antagonist
IsunakinraPhase 3——
IboctadekinPhase 2IL18R1, IL18RAPIL18 Receptor agonist
VevoctadekinPhase 2——
Nogapendekin alfa inbakicept—Interleukin-15 receptorInterleukin-15 receptor agonist
Nogapendekin alfaPhase 3——
Larnefpendekin alfaPhase 2——
Cintredekin besudotoxPhase 3IL13RA1, IL4R, IL13RA2, EEF2Interleukin 13 receptor binding agent

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.